Grace Therapeutics, Inc.

📈 Chart on TradingView 💰 Financials on Finviz

$GRCE

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Healthcare

Sector

Biotechnology

Industry

Prashant Kohli

CEO

Employees

$1.78

Current Price

$34.17M

Market Cap

52W Low$1.67

Current$1.783.1% above low, 96.9% below high

52W High$5.18

Insider Activity Statistics

Aggregated buying and selling activity by time period

Period	Type	Insiders	Transactions	Value	Shares	Buy/Sell Ratio
1 week	Buys	1	3	$33,019.28	18,442	All Buys
1 week	Sells	0	0	-	-	All Buys
2 weeks	Buys	1	4	$150,427.28	84,853	All Buys
2 weeks	Sells	0	0	-	-	All Buys
1 month	Buys	1	10	$350,373.45	188,779	All Buys
1 month	Sells	0	0	-	-	All Buys
2 months	Buys	1	18	$537,392.41	279,624	All Buys
2 months	Sells	0	0	-	-	All Buys
3 months	Buys	2	22	$807,494.23	406,461	All Buys
3 months	Sells	0	0	-	-	All Buys
See activity going back 12 months — create a free account

Insider Transactions

Recent purchases and sales by company insiders

Date	Insider	Type	Shares	Price	Value	Actions
Nov 5, 2026	Opaleye Management Inc. 10% Owner	Purchase	3,087	$1.77	$5,478.19	View Details
Nov 4, 2026	Opaleye Management Inc. 10% Owner	Purchase	5,027	$1.80	$9,060.16	View Details
Nov 3, 2026	Opaleye Management Inc. 10% Owner	Purchase	10,328	$1.79	$18,480.92	View Details
Oct 22, 2026	Opaleye Management Inc. 10% Owner	Purchase	21,390	$1.93	$41,192.86	View Details
Oct 26, 2026	Opaleye Management Inc. 10% Owner	Purchase	66,411	$1.77	$117,408.01	View Details
Oct 19, 2026	Opaleye Management Inc. 10% Owner	Purchase	4,256	$1.88	$8,001.28	View Details
Oct 16, 2026	Opaleye Management Inc. 10% Owner	Purchase	36,347	$1.89	$68,757.62	View Details
Oct 14, 2026	Opaleye Management Inc. 10% Owner	Purchase	11,233	$1.93	$21,734.73	View Details
Oct 15, 2026	Opaleye Management Inc. 10% Owner	Purchase	23,485	$1.95	$45,685.37	View Details
Oct 12, 2026	Opaleye Management Inc. 10% Owner	Purchase	7,215	$2.02	$14,574.30	View Details
Oct 9, 2026	Opaleye Management Inc. 10% Owner	Purchase	5,340	$2.04	$10,918.16	View Details
Oct 8, 2026	Opaleye Management Inc. 10% Owner	Purchase	2,077	$2.02	$4,190.35	View Details
Oct 1, 2026	Opaleye Management Inc. 10% Owner	Purchase	38,796	$2.04	$78,961.50	View Details
Oct 5, 2026	Opaleye Management Inc. 10% Owner	Purchase	1,694	$2.06	$3,489.64	View Details
Oct 2, 2026	Opaleye Management Inc. 10% Owner	Purchase	20,000	$2.07	$41,368.00	View Details
Sep 29, 2026	Opaleye Management Inc. 10% Owner	Purchase	7,849	$2.09	$16,404.41	View Details
Sep 21, 2026	Opaleye Management Inc. 10% Owner	Purchase	9,771	$2.10	$20,519.10	View Details
Sep 23, 2026	Opaleye Management Inc. 10% Owner	Purchase	5,318	$2.10	$11,167.80	View Details
Sep 9, 2026	Opaleye Management Inc. 10% Owner	Purchase	5,836	$2.09	$12,196.66	View Details
Sep 8, 2026	Opaleye Management Inc. 10% Owner	Purchase	9,393	$2.10	$19,699.00	View Details

Showing 1–20 of 22 transactions

Upcoming Earnings

Scheduled earnings reports

Nov 12, 2026

EPS

Estimated-$0.15

ActualN/A

Revenue

Estimated$1.00M

ActualN/A

Past Earnings

Historical earnings results

No earnings data in the last 3 months. Sign up free to see 12 months of history.

Related Activity

Cross-company insider connections and cluster buy signals

Insiders Also Active At

Insiders at this company also hold positions or have traded at these companies:

$CDXS — CODEXIS, INC.via Opaleye Management Inc.$SNVW — SANUWAVE Health, Inc.via Opaleye Management Inc.$ACOG — Alpha Cognition Inc.via Opaleye Management Inc.$SLGL — Sol-Gel Technologies Ltd.via Opaleye Management Inc.$ETON — Eton Pharmaceuticals, Inc.via Opaleye Management Inc.

Average Insider